3 hrs ago

Brokerages Split Over PB Fintech’s Insurance Commission Outlook

Brokerages Split Over PB Fintech’s Insurance Commission Outlook
PB Fintech: Ambit sees IRDAI commission hit even as BofA raises target price · financialexpress.com

PB Fintech runs Policybazaar, a platform that helps people buy insurance.

Insurance companies pay the platform commissions for distributing their products.

India’s insurance regulator has proposed rules that could reduce some of these commissions.

Ambit Capital says this could hurt PB Fintech’s profits quickly and force the company to reduce costs.

It still rates the shares Buy because lower commissions could hurt competing sales channels more severely.

BofA Global Research is more optimistic about the company’s longer-term growth.

It says renewals are growing faster than new insurance sales and cost less to acquire.

BofA also sees potential in PB Partners, international operations and reinsurance broking.

However, BofA remains Neutral because the final commission rules are uncertain.

Key facts

Ambit rating
Buy
Ambit target price
Rs 2,305
BofA rating
Neutral
BofA target price
Rs 1,970, raised from Rs 1,800
Estimated commission impact
Ambit expects PB Fintech’s blended commission rate to fall about 40% in FY28 to roughly 10%.
Renewal growth outlook
BofA estimates renewal premiums will grow at a 39% CAGR from FY26 to FY29, versus 29% for new business.
BofA FY28 estimates
Revenue of Rs 12,268 crore and adjusted EBITDA of Rs 1,592 crore.

Quotes

BofA Global Research

Brokerage research firm covering PB Fintech

“The proposed sharp commission cuts could hurt higher upfront commission-led channels more, especially agents in health and banks/NBFCs in life, improving PB’s channel attractiveness and aiding market-share shift to PB”
financialexpress.com
“Policybazaar is moving toward a more attractive economic model, with renewals growing faster than new business, supporting long-term profitability”
financialexpress.com

Sources

Related news